References
- Wing DA, Rakall A, JonesMM, et al. Misoprostol:an effective agent for cervical ripening and labor induction. Am J Obstet Gynecol 1995;172:1811�16
- Danielsson KG, Marions L, Rodriguez A, et al. Comparison between oral and vaginal administration of misoprostol on uterine contractility. Obstet Gynecol 1999;93: 275�80
- Gumezoglu AM, Villar J, Ngoc NT, et al. WHO multicentre randomizedtrialofmisoprostolin the management of the third stage of labour. Lancet 2001;358:689�95
- Khan R, El-Refaey H. Pharmacokinetics and adverse-effect profileof rectallyadministeredmisoprostolin the third stage of labor. Obstet Gynecol 2003;101:968�74
- Caliskan E, Dilbaz B,MeydanliMM, et al. Oral misoprostol for the third stage of labor: a randomized controlled trial. Obstet Gynecol 2003;101:921�8
- Perrone JF, Caldito G, Mailhes JB, et al. Oral misoprostol before office endometrial biopsy. Obstet Gynecol 2002;99: 439�44
- El-Rafaey H, O�Brien P, MorafaW, et al. Misoprostol for the third stage of labour. Lancet 1996;347:1257�9
- Daly S, Andolina K, Tolosa JE, et al. Randomized controlled trial of misoprostol versus oxytocin preventing postpartum blood loss. Am J Obstet Gynecol 1999;180:S68
- KundodyiwaTW,Majoko F, RusakanikoS. Misoprostolversus oxytocin in the third stage of labor. Int J Gynaecol Obstet 2001;75:235�41
- Abdel-Aleem H, Villar J, Gulmezoglu AM, et al. The pharmacokinetics of the prostaglandin E1 analogue misoprostol in plasma and colostrum after postpartum oral administration. Eur J Obstet Gynecol Reprod Biol 2003;108: 25�8
- Karim A. Antiulcer prostaglandin misoprostol: single and multiple dose pharmacokinetic profile. Searle Research and Development. Prostaglandin 1987;Suppl 3:40�50
- Zieman M, Fong SK, Benowitz NL, et al. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 1997;90:88�92
- Tang OS, Schweer H, SeyberthHW, et al. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 2002;17:332�6
- Chong YS, Chua S, El-Rafaey H, et al. Postpartumintrauterine pressurestudiesof the uterotoniceffect of oral misoprostoland intramuscular syntometrine. Br J Obstet Gynaecol 2001;108: 41�7
- El-Rafaey H, O�Brien P, Morafa W, et al. Use of oral misoprostol in the prevention of postpartum haemorrhage. Br J Obstet Gynaecol 1997;104:336�9
- Surbek DV, Fehr PM, Hoesli I, et al. Oralmisoprostol for third stage of labor: a randomized placebo controlled trial. Obstet Gynecol 1999;94:255�8
- Joint WHO/UNFPA/ UNICEF/ World Bank statement. Reduction of Maternal Mortality. Geneva: World Health Organization, 1997
- O�Brien P, El-Rafaey H, GordonA, et al. Rectallyadministered misoprostol for the treatment of postpartum hemorrhage unresponsive to oxytocin and ergometrine: a descriptive study. Obstet Gynecol 1998;92:212�14
- Karim A, Rozek L, Smith M, et al. Effects of food and antacid on oral absorption of misoprostol, a synthetic prostaglandin E1 analog. Clin Pharmacol 1989;29:439�43